China Cord Blood Corporation Receives $512 Million Take-Private Offer

China Cord Blood Corp., which claims to be China's largest provider of cord banking services, has received a take-private offer of $6.40 per share from Golden Meditech Holdings, the company's largest shareholder. Apparently, the offer was heavily anticipated because the shares closed much higher -- $7.22 -- on Friday. On March 19, when Jayhawk Capital issued an open letter asking China Cord Blood's board to do something about the company's stock price, China Cord Blood was trading for $5.54.

Help employers find you! Check out all the jobs and post your resume.